UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms

Clinical cancer research, 2007-09, Vol.13 (18), p.5556s-5563s

2007

Volltextzugriff (PDF)

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody

Blood, 2009-01, Vol.113 (5), p.1062-1070

2009

Volltextzugriff (PDF)

Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma

Blood, 2009-06, Vol.113 (24), p.6161-6171

2009

Volltextzugriff (PDF)

Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines

Clinical cancer research, 2009-04, Vol.15 (8), p.2808-2817

2009

Volltextzugriff (PDF)

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Clinical cancer research, 2004-04, Vol.10 (8), p.2868-2878

2004

Volltextzugriff (PDF)

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Clinical cancer research, 2005-07, Vol.11 (14), p.5257-5264

2005

Volltextzugriff (PDF)

CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy

Clinical cancer research, 2004-10, Vol.10 (19), p.6606-6611

2004

Volltextzugriff (PDF)

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target

Oncotarget, 2018-06, Vol.9 (48), p.28989-29006

2018

Volltextzugriff (PDF)

A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy

Molecular cancer therapeutics, 2004-12, Vol.3 (12), p.1559-1564

2004

Volltextzugriff (PDF)

Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

Clinical cancer research, 2003-12, Vol.9 (17), p.6567-6571

2003

Volltextzugriff (PDF)

Advantage of a Residualizing Iodine Radiolabel in the Therapy of a Colon Cancer Xenograft Targeted with an Anticarcinoembryonic Antigen Monoclonal Antibody

Clinical cancer research, 2005-04, Vol.11 (7), p.2727-2734

2005

Volltextzugriff (PDF)

A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies

Clinical cancer research, 2007-09, Vol.13 (18), p.5564s-5571s

2007

Volltextzugriff (PDF)

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

Molecular Immunology, 2007-02, Vol.44 (6), p.1331-1341

2007

Volltextzugriff (PDF)

CD45 monoclonal antibody mediated cytolysis of human NK and T lymphoma cells

Haematologica (Roma), 2006-07, Vol.91 (7), p.866A-866A

Stein, Rhona

2006

Volltextzugriff (PDF)

CD20-targeted tetrameric interferon-α, a novel and potent immunocytokine for the therapy of B-cell lymphomas

Blood, 2009-10, Vol.114 (18), p.3864-3871

2009

Volltextzugriff (PDF)

The epithelial/carcinoma antigen EGP‐1, recognized by monoclonal antibody RS7–3G11, is phosphorylated on serine 303

International journal of cancer, 1995-08, Vol.62 (4), p.472-479

1995

Volltextzugriff (PDF)

SCLC‐cluster‐2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP‐2

International journal of cancer, 1994, Vol.57 (S8), p.60-63

1994

Volltextzugriff (PDF)

A Bispecific Antibody-IFNα2b Immunocytokine Targeting CD20 and HLA-DR Is Highly Toxic to Human Lymphoma and Multiple Myeloma Cells

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7600-7609

2010

Volltextzugriff (PDF)

Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (20), p.8384-8392

2008

Volltextzugriff (PDF)

CD200 Is Preferentially Expressed in CD138 dim Multiple Myeloma Cells: Implications for a Myeloma Stem Cell Subpopulation with Potential Immune-Resistance

Blood, 2009-11, Vol.114 (22), p.4877-4877

2009

Volltextzugriff (PDF)

Improved Therapy of Multiple Myeloma by Combining Milatuzumab (Anti-CD74 Humanized mAb) and Bortezomib: In Vitro and In Vivo Results

Blood, 2007-11, Vol.110 (11), p.1176-1176

2007

Volltextzugriff (PDF)

Abstract 755: Dendritic-cell vaccine: Cross-presentation of carcinoembryonic antigen (CEA) by dendritic cells (DCs) through a fusion protein targeting CD74 on DCs

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.755-755

2011

Volltextzugriff (PDF)

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

Blood, 2011-08, Vol.118 (7), p.1877-1884

2011

Volltextzugriff (PDF)

Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

Blood, 2010-06, Vol.115 (25), p.5180-5190

2010

Volltextzugriff (PDF)

Prevention of Acute Graft-Versus-Host Disease in Human/Mouse Xenogeneic SCID Mouse Model by Humanized Anti-CD74 Monoclonal Antibody, Milatuzumab

Blood, 2012-11, Vol.120 (21), p.4105-4105

2012

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(91)

Erscheinungsjahr

n.n

Thema

Humans
(60)
Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Animals
(47)
Biological And Medical Sciences
(46)
Medical Sciences
(43)
Mice
(40)
Oncology
(36)
Female
(29)
Antibodies, Monoclonal - Therapeutic Use
(21)
Mice, Nude
(18)
Transplantation, Heterologous
(18)
Antineoplastic Agents
(17)
Pharmacology. Drug Treatments
(17)
Tumor Cells, Cultured
(17)
Tumors
(16)
Neoplasm Transplantation
(14)
Tissue Distribution
(14)
Antibodies, Monoclonal - Immunology
(13)
Radioimmunotherapy
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody

Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma

Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy

The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target

A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy

Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate

Advantage of a Residualizing Iodine Radiolabel in the Therapy of a Colon Cancer Xenograft Targeted with an Anticarcinoembryonic Antigen Monoclonal Antibody

A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

CD45 monoclonal antibody mediated cytolysis of human NK and T lymphoma cells

CD20-targeted tetrameric interferon-α, a novel and potent immunocytokine for the therapy of B-cell lymphomas

The epithelial/carcinoma antigen EGP‐1, recognized by monoclonal antibody RS7–3G11, is phosphorylated on serine 303

SCLC‐cluster‐2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP‐2

A Bispecific Antibody-IFNα2b Immunocytokine Targeting CD20 and HLA-DR Is Highly Toxic to Human Lymphoma and Multiple Myeloma Cells

Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics

CD200 Is Preferentially Expressed in CD138 dim Multiple Myeloma Cells: Implications for a Myeloma Stem Cell Subpopulation with Potential Immune-Resistance

Improved Therapy of Multiple Myeloma by Combining Milatuzumab (Anti-CD74 Humanized mAb) and Bortezomib: In Vitro and In Vivo Results

Abstract 755: Dendritic-cell vaccine: Cross-presentation of carcinoembryonic antigen (CEA) by dendritic cells (DCs) through a fusion protein targeting CD74 on DCs

Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers

Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

Prevention of Acute Graft-Versus-Host Disease in Human/Mouse Xenogeneic SCID Mouse Model by Humanized Anti-CD74 Monoclonal Antibody, Milatuzumab

Suchergebnisse filtern